Cellectar Biosciences, Inc.
CLRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001279704
No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.08M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Cellectar Biosciences, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +6 vs. Q3 2023
- Shares held
- 8.60M
- +7.15M (+490.0%) vs. Q3 2023
- Total value
- $23.9M
- +$20.0M (+519.6%) vs. Q3 2023
- New holders
- 8
- 7 more added
- Sold out
- 2
- 5 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $9.08M |
| Q1 2026 | 19 | $812.9K |
| Q4 2025 | 20 | $1.04M |
| Q3 2025 | 21 | $1.65M |
| Q2 2025 | 19 | $734.0K |
| Q1 2025 | 32 | $1.63M |
| Q4 2024 | 30 | $1.52M |
| Q3 2024 | 35 | $30.0M |
| Q2 2024 | 37 | $28.3M |
| Q1 2024 | 45 | $36.3M |
| Q4 2023 | 26 | $23.9M |
| Q3 2023 | 20 | $3.85M |
| Q2 2023 | 21 | $3.08M |
| Q1 2023 | 21 | $2.43M |
| Q4 2022 | 26 | $3.22M |
| Q3 2022 | 22 | $2.14M |
| Q2 2022 | 33 | $3.61M |
| Q1 2022 | 32 | $4.69M |
| Q4 2021 | 42 | $4.38M |
| Q3 2021 | 40 | $6.77M |
| Q2 2021 | 46 | $14.9M |
| Q1 2021 | 45 | $24.2M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Cellectar Biosciences, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 16 | $44 | 0.00% | +16 | New |
| FMR LLC | 18 | $50 | 0.00% | −30−62.5% | Reduced |
| AllSquare Wealth Management LLC | 18 | $50 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 20 | $55 | 0.00% | +9+81.8% | Added |
| Harbour Investments, Inc. | 40 | $111 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 60 | $166 | 0.00% | −11−15.5% | Reduced |
| US Bancorp | 285 | $789 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 521 | $1.44K | 0.00% | −21−3.9% | Reduced |
| UBS Group AG | 1,200 | $3.32K | 0.00% | −56−4.5% | Reduced |
| Tower Research Capital LLC (TRC) | 3,686 | $10.2K | 0.00% | −2,278−38.2% | Reduced |
| Commerce Bank | 12,000 | $33.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 12,686 | $35.1K | 0.00% | +12,686 | New |
| Morgan Stanley | 15,056 | $41.7K | 0.00% | +56+0.4% | Added |
| State Street Corp | 15,714 | $43.5K | 0.00% | 00.0% | Unchanged |
| Coastal Bridge Advisors, LLC | 23,000 | $63.7K | 0.02% | +23,000 | New |
| GWM Advisors LLC | 21,013 | $77.5K | 0.00% | +21,013 | New |
| BlackRock Inc. | 57,042 | $158.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 68,870 | $190.8K | 0.00% | +6,022+9.6% | Added |
| Citadel Advisors LLC | 69,007 | $191.1K | 0.00% | +69,007 | New |
| Acuta Capital Partners, LLC | 477,500 | $1.32M | 0.74% | +356,200+293.7% | Added |
| Vanguard Group Inc | 482,890 | $1.34M | 0.00% | +307,006+174.6% | Added |
| Worth Venture Partners, LLC | 693,909 | $1.92M | 1.04% | +414,786+148.6% | Added |
| Nantahala Capital Management, LLC | 1,350,578 | $3.74M | 0.37% | +1,350,578 | New |
| ADAR1 Capital Management, LLC | 1,378,082 | $3.82M | 1.71% | +1,378,082 | New |
| AIGH Capital Management LLC | 1,915,220 | $5.31M | 2.10% | +1,237,709+182.7% | Added |
| Rosalind Advisors, Inc. | 2,005,658 | $5.56M | 4.65% | +2,005,658 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −21,690−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |